Evidence map›Paper›PMID 35359074›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2022

[Glucose-6 phosphatase catalytic subunit inhibits the proliferation of liver cancer cells by inducing cell cycle arrest].

X Lin, X M Pan, Z K Peng, K Wang, N Tang

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. [Cyclin A1 affects the invasion, metastasis, and prognosis of hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

X LinThe Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Chongqing 400016, China.
X M PanThe Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Chongqing 400016, China.
Z K PengChongqing Yucai Middle School, Chongqing 400050, China.
K WangThe Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Chongqing 400016, China.
N TangThe Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Chongqing 400016, China.
Ministry of Education · THChongqing University · CN

Funding

Basic and Frontier Research Projects of Chongqing Science and Technology Commission cstc2019jcyj-msxmX0587, cstc2018jcyjAX0254Chongqing "300" Science and Technology Leading Talents Support Project CSTCCXLJRC201719The National Natural Science Foundation of China 82073251, 82072286, 81872270the Science and Technology Research Program of Chongqing Municipal Education Commission KJQN201900429, KJZD-M202000401the Young Eagle Plan of Chongqing Municipal Education Commission CY200406
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell Cycle CheckpointsGene Expression Regulation, NeoplasticLiver NeoplasmsCatalytic DomainCell Line, TumorCell ProliferationGlucose-6-PhosphataseHumansGlucose-6-PhosphataseCell cycleCell proliferationGlucose-6 phosphatase catalytic subunitHepatocellular carcinoma

Identifiers

PMID35359074
PMCPMC12770279
OpenAlexW4226048685

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.